A 5-year-old girl is brought to the pediatric clinic for a well-child visit prior to starting kindergarten. She was diagnosed with polyarticular juvenile idiopathic arthritis two years ago and is currently maintained on a regimen of methotrexate and etanercept. The patient's mother states that the child has not received any immunizations since her 2-year-old well-child visit. She has no other medical conditions and takes no other medications. Vital signs are within normal limits. Physical examination shows no active joint swelling, warmth, or limitation in range of motion. Which of the following is the most appropriate immunization plan for this patient?
- Administer DTaP and IPV, and withhold MMR and varicella vaccinesCevap
- BAdminister DTaP, IPV, MMR, and varicella vaccines
- CWithhold all routine immunizations until immunosuppressive therapy is discontinued
- DAdminister DTaP, IPV, and the live-attenuated intranasal influenza vaccine
- EAdminister DTaP and IPV, and substitute with inactivated forms of MMR and varicella vaccines
Cevap
Administer DTaP and IPV, and withhold MMR and varicella vaccines
The correct approach is to administer only the inactivated vaccines (DTaP and IPV) and withhold the live-attenuated vaccines (MMR and varicella). Children aged 4 to 6 years are routinely scheduled to receive the DTaP, IPV, MMR, and varicella vaccines. However, this patient is taking etanercept (a TNF-alpha inhibitor) and methotrexate, which cause significant immunosuppression. Live-attenuated vaccines contain weakened but viable pathogens that can cause severe, disseminated infection in immunocompromised hosts. Therefore, MMR and varicella are strictly contraindicated. Inactivated vaccines, such as DTaP and IPV, contain no live virus or bacteria and cannot cause disease, making them safe to administer, although the patient's immune response to the vaccine may be slightly blunted.
Adım Adım Çözüm
Anahtar Kavram
Live-attenuated vaccines (e.g., MMR, varicella, intranasal influenza) are strictly contraindicated in patients receiving potent immunosuppressive therapy, such as TNF-alpha inhibitors. Inactivated vaccines should be administered according to the normal schedule.